Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ACTRN12625001414404) titled 'Personalised daily body-clock tracking and circadian light therapy retiming to improve sleep, performance, health and safety' on Dec. 16, 2025.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: Peter Catcheside, FHMRI Sleep Health, Flinders University
Condition:
Delayed sleep-wake phase disorder
Delayed sleep-wake phase disorder
Neurological - Other neurological disorders
Intervention:
Light therapy involves personalised recommendations around when to seek an...